Results 31 to 40 of about 4,080,754 (294)

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

open access: yesEmerging Infectious Diseases, 2004
Severe acute respiratory syndrome (SARS) is an infectious disease caused by a newly identified human coronavirus (SARS-CoV). Currently, no effective drug exists to treat SARS-CoV infection.
Emily L.C. Tan   +6 more
doaj   +1 more source

Ribonucleases as antiviral agents [PDF]

open access: yesMolecular Biology, 2014
Many ribonucleases (RNases) are able to inhibit the reproduction of viruses in infected cell cultures and laboratory animals, but the molecular mechanisms of their antiviral activity remain unclear. The review discusses the well-known RNases that possess established antiviral effects, including both intracellular RNases (RNase L, MCPIP1 protein, and ...
Ilinskaya O., Mahmud R.
openaire   +4 more sources

Metal Complexes as Antiviral Agents for SARS‐CoV‐2

open access: yesChemBioChem, 2021
The severe acute respiratory syndrome – coronavirus 2 (SARS‐CoV‐2), the infectious agent responsible for COVID‐19 – has caused more than 2.5 million deaths worldwide and triggered a global pandemic. Even with successful vaccines being delivered, there is
J. Karges, Seth M. Cohen
semanticscholar   +1 more source

Engineering recombinantly expressed lectin-based antiviral agents

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
Cyanovirin-N (CV-N), a lectin from Nostoc ellipsosporum was found an infusion inhibitory protein for human immunodeficiency virus (HIV)-1. A tandem-repeat of the engineered domain-swapped dimer bound specific sites at hemagglutinin (HA), Ebola and HIV ...
Irene Maier
doaj   +1 more source

Seven classes of antiviral agents

open access: yesCellular and Molecular Life Sciences, 2022
The viral epidemics and pandemics have stimulated the development of known and the discovery of novel antiviral agents. About a hundred mono- and combination antiviral drugs have been already approved, whereas thousands are in development.
A. Ianevski   +7 more
semanticscholar   +1 more source

Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy

open access: yesFrontiers in Cellular and Infection Microbiology, 2019
Hand, foot, and mouth disease (HFMD) is a global health concern, especially in the Asia-Pacific region. HFMD caused by Enterovirus 71 (EV71) and Coxsackievirus A16 (CVA16) infection is usually self-limited but occasionally leads to severe pulmonary edema,
Huiqiang Wang   +7 more
doaj   +1 more source

Comparison of Antiviral Agents for Seasonal Influenza Outcomes in Healthy Adults and Children

open access: yesJAMA Network Open, 2021
Key Points Question What antiviral agents for treating seasonal influenza are associated with the most safety and best outcomes among healthy adults and children?
Jen-Wei Liu   +4 more
semanticscholar   +1 more source

Kinase Inhibitors as Underexplored Antiviral Agents

open access: yesJournal of Medicinal Chemistry, 2021
Viral infections are a major health problem; therefore, there is an urgent need for novel therapeutic strategies. Antivirals used to target proteins encoded by the viral genome usually enhance drug resistance generated by the virus.
Javier García-Cárceles   +3 more
semanticscholar   +1 more source

Simultaneous Antibiofilm and Antiviral Activities of an Engineered Antimicrobial Peptide during Virus-Bacterium Coinfection

open access: yesmSphere, 2016
Antimicrobial-resistant infections are an urgent public health threat, and development of novel antimicrobial therapies has been painstakingly slow. Polymicrobial infections are increasingly recognized as a significant source of severe disease and also ...
Jeffrey A. Melvin   +6 more
doaj   +1 more source

Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model

open access: yesmBio, 2022
Amino acid substitutions I38T and E23K in the influenza polymerase acidic (PA) protein lead to reduced susceptibility to the influenza antiviral drug baloxavir.
Paulina Koszalka   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy